Epstein Secrets

a Man Charged With Threatening "To Cause Pain" To Member Of Congress. The Washington Times (1/22, Mordock, 626K) reports that Jason Robert Karimi of St. Paul, Minnesota "was charged Friday with threatening to 'cause pain in every way possible' to a member of the U.S. House of Representatives." The man "l

S Two Men Plead Guilty To Charges In Fire At Minneapolis Police Precinct During George Floyd Protests. The Hill (1/23, Polus, 5.69M) reports, "Two St. Paul, Minn., men have pleaded guilty to charges in a fire at a Minnesota police precinct during the George Floyd protests last May, according to the Dep

the announcement "came shortly after news emerged that he would speak with Russian President Vladimir Putin on Monday about obtaining doses of the Sputnik V COVID-19 vaccine." The AP adds, "Other Latin American leaders who have tested positive for the coronavirus are Brazil's President Jair Bolsonaro,

suspected-in-st-paul-fatal-shooting/> (11/24, Gottfried, 407K) reports, "FBI agents arrested a man in Chicago in connection with a fatal shooting in St. Paul, the police department announced Tuesday." Leroy Spivey, 34, "was killed Nov. 14 near Rice Street and Sherburne Avenue. The FBI took Edward Lee Gray

imes.corn/2020/11/24/world/sputnik-vaccine-russia.html> (11124, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

ing. The St. Paul (MN) Pioneer Press (11/24, Gottfried, 407K) reports, "FBI agents arrested a man in Chicago in connection with a fatal shooting in St. Paul, the police department announced Tuesday." Leroy Spivey, 34, "was killed Nov. 14 near Rice Street and Sherburne Avenue. The FBI took Edward Lee Gra

tgoing Trump Administration." While the New York Times (11/24, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level